Acadia Pharmaceuticals Inc (ACAD)

Sales/Maturities of Investments

$176.50M

Quarterly · Period ending: · USD

ACAD logo

ACAD Sales/Maturities of Investments

Latest reported$176.50M
ACAD Quarterly Sales/Maturities of Investments ($2.79M → $176.50M)
High-resolution chart · PNG

ACAD sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Acadia Pharmaceuticals Inc Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
176,500,000
86,500,000
105,750,000
125,589,000
131,390,000
130,800,000
111,850,000
69,100,000
81,500,000
66,115,000
103,760,000
71,363,000
7,500,000
259,410,000
75,800,000
159,690,000
69,580,000
131,345,000
110,500,000
95,000,000
57,500,000
159,817,000
124,141,000
154,710,000
129,838,000
131,315,000
108,838,000
94,185,000
113,379,000
97,525,000
44,116,000
42,411,000
58,740,000
116,411,000
106,892,000
123,221,000
147,824,000
194,166,000
159,876,000
111,801,000
87,183,000
72,077,000
110,578,000
99,165,000
120,347,000
89,107,000
68,720,000
57,525,000
70,208,000
51,815,000
34,498,000
21,196,000
8,620,000
21,773,000
6,065,000
2,878,000
14,087,000
7,918,000
12,067,000
11,139,000
15,231,000
15,612,000
10,449,000
14,350,000
14,062,000
14,625,000
19,588,000
14,561,000
11,671,000
13,930,000
35,424,000
26,749,000
35,915,000
51,824,000
57,918,000
54,487,000
31,318,000
37,022,000
44,375,000
18,000,000
13,064,000
7,727,000
10,565,000
20,428,000
9,257,000
8,643,000
14,243,000
6,500,000
6,317,900
2,792,100
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.